 |
||||||||||||||||||
|
Speakers The speaker panel for the Washington Vaccine Forum 2010 is now almost complete. Speakers who have already confirmed their participation include: Dr Robin Robinson, Director, Biomedical Advanced Research & Development Authority (BARDA), Office of the Assistant Secretary for Preparedness & Response (ASPR), US Department of Health & Human Services Merlin Robb, MD, HJF HIV Program Director, Henry M. Jackson Foundation for the Advancement of Military Medicine, Deputy Director (Clinical), US Military HIV Research Program (MHRP) Dr Norman W. Baylor, Director, Office of Vaccines Research & Review (OVRR), CBER, US Food & Drug Administration Allan Saul PhD, CEO, Novartis Vaccines Institute for Global Health Dr Gary J. Nabel, Director, Vaccine Research Center, National Institute of Allergy & Infectious Diseases (NIAID), NIH Dr John Purves, Head of Sector, Quality of Medicines, European Medicines Agency (EMEA) Dr Bruce G. Gellin, Director, National Vaccine Program Office, Office of Public Health & Science, Office of the Assistant Secretary for Health, US Department of Health & Human Services Dr Allan P. Jarvis, Vice President, Corporate Development, sanofi pasteur Dr Hartmut Ehrlich, Vice President, Global R&D, Baxter BioScience Jon Kim Andrus, MD, Deputy Director, Pan American Health Organization (PAHO) Dr Steve G. Reed, CEO, Immune Design & Founder, IDRI Melinda Wharton, MD MPH, Acting Director of National Centre for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention Dr Joe Cohen, Vice President, Emerging Diseases & HIV Vaccines, Research & Development, GlaxoSmithKline Biologicals Dr John Boslego, Director, Vaccine Development Global Program, PATH Dr Michael V. Callahan, Program Manager, Rapid Vaccine Assessment, Defense Advanced Research Projects Agency (DARPA) Robert V. House, PhD, President, DynPort Vaccine Company LLC, A CSC Company Nima Farzan, Vice President of US Marketing, Novartis Vaccines & Diagnostics Inc Dr Jan ter Meulen, Executive Director, Vaccine Basic Research, Merck Research Laboratories Dr Michael Perdue, Director – Influenza & Emerging Diseases Program, Biomedical Advanced Research & Development Authority, Office of the Assistant Secretary for Preparedness & Response, US Department of Health & Human Services Stephen L. Hoffman, MD, Chief Executive & Scientific Officer, Sanaria Inc Chris Varma, PhD, Partner, Flagship Ventures Bruce Innis, MD, Vice President & Director, Global Clinical R&D, Vaccines for Influenza, MMR, Varicella & Dengue, GlaxoSmithKline Susan Ano, PhD, Chief, Infectious Diseases & Medical Engineering Branch, Office of Technology Transfer, National Institutes of Health Dr Heather L. Davis, Executive Director & Ottawa Site Head, Vaccines Research, Pfizer Global R&D Dr Alan Shaw, President & CEO, Vaxinnate Corporation Dr Clement Lewin, Head, Strategic Immunization Planning, Novartis Vaccines and Diagnostics Dr Linda C. Lambert PhD, Chief, Respiratory Diseases Branch, Division of Microbiology & Infectious Diseases, NIAID Vic Schmitt, Venture Partner, Bay City Capital Dr W. James Jackson, Chief Scientific Officer, Emergent BioSolutions Inc Diana Lanchoney, MD, Executive Director, Vaccine Research, Merck Research Laboratories Harry Kleanthous, PhD, Senior Director & Head, Discovery USA, sanofi pasteur Philip R. Dormitzer, MD, PhD, Senior Director, Senior Project Leader, Viral Vaccine Research, Novartis Vaccines and Diagnostics Eric Victory, Associate Director, Business Development, MedImmune Dr Rahul Singhvi, President & CEO, Novavax, Inc Eric Rosenthal, MD, MPH, FAAP, Clinical Assistant Professor of Medicine & of Health Policy, George Washington University Medical Center, Medical Director, Municipal & Regional Affairs, Child Health Advocacy Institute, Senior Clinical Associate, Emergency Department, Children's National Medical Center Sandy Wrobel, Chief Executive Officer & Managing Director, Applied Strategies Professor Alexander von Gabain, Strategic Advisor to the Board, Intercell AG Lewellys F. Barker, MD, MPH, Senior Medical Advisor, Aeras Global TB Vaccine Foundation Dr Seth Rudnick, Venture Partner, Canaan Partners Dr Mitchell H. Gold, President & CEO, Dendreon Corporation Christian Loucq, MD, Director, The PATH Malaria Vaccine Initiative Nicholas A. Kartsonis, MD, Senior Director, Clinical Research - Infectious Diseases/Vaccines, Merck & Co, Inc Gregg C. Sylvester, MD, MPH, Head of Adult & Adolescent Vaccines for Medical Affairs & Policy, Merck Vaccines & Infectious Diseases Michael Greenberg, MD, MPH, Director of Clinical Development, Vaccines, CSL Jose Ochoa, Vice President Business Development, Emergent BioSolutions Inc John Clerici, Partner, McKenna Long & Aldridge Dr Alain Rolland, Executive Vice President, Product Development, Vical Dr Nicole Frahm, Associate Laboratory Director, HVTN, Fred Hutchinson Cancer Research Center Dr Ginamarie Foglia, Clinical Director, Sanofi Pasteur Michael J. Werner, Partner, Holland & Knight Dr Alfredo Nicosia, Chief Scientific Officer, Okairos Eddy A. Bresnitz, MD, MS, Medical Director, Adult Vaccine Medical Affairs & Policy, Merck Vaccine Division Isabelle Claxton, Director, Public Policy & Advocacy, GlaxoSmithKline Vaccines Harriet L. Robinson, PhD, Chief Scientific Officer, GeoVax Inc Drew Hannaman, Vice President, R&D, Ichor Medical Systems, Inc Dr Manon Cox, COO, Protein Sciences Corporation Dr Beth-Ann Coller, Senior Vice President for Research & Development, Hawaii Biotech, Inc Dr Vidadi Yusibov, Executive Director, Fraunhofer USA Center for Molecular Biotechnology Dr Robert F. Bargatze, CSO & Executive Vice President, LigoCyte Pharmaceuticals John Trizzino, Senior Vice President of International & Government Alliances, Novavax, Eric Faulkner, MPH, Senior Director, US Market Access & Reimbursement, RTI Health Solutions Dr Ronald W. Ellis, Senior Vice President & Chief Technology Officer, NasVax Ltd, Israel Kun Yao, DVM, PhD, Associate Director, Manufacture Science & Technology, MedImmune, Inc Fabio Bagnoli, PhD, Associate Project Leader, Novartis Vaccines and Diagnostics
©Copyright Phacilitate Limited 2009
|
  Click here to download the last three North American Vaccine Forum Main Announcements
|
||||||||||||||||
